Surgery Partners Inc (NASDAQ: SGRY) has reported E.P.S. of $-0.04 for its third fiscal quarter (ending September 30) versus $-0.28 for the same period a year ago. This result fell short of the consensus estimate of $0.14 by $-0.19. For the latest four quarters through September 30, E.P.S. were $-0.32 versus $-0.35 for the same period a year ago.
Recent Price Action
Surgery Partners Inc (NASDAQ: SGRY) stock enjoyed a major increase of 14.0% on 11/7/23. The shares closed at $28.28. The stock has been weak relative to the market over the last nine months but has risen 26.7% during the last week.
Current PriceTarget Research Rating
SGRY is expected to continue to be a modest Value Builder reflecting capital returns that are forecasted to exceed the cost of capital.
Surgery Partners has a current Value Trend Rating of C (Low Neutral). This rating combines highly consistent signals from two proprietary PTR measures of a stock’s attractiveness. Surgery Partners has a neutral Appreciation Score of 46 and a neutral Power Rating of 45, producing the Low Neutral Value Trend Rating.
Rating Review
In light of this new information and very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment